Intel grants Atom chip access to stealth startup RosaicLabs in rare IP deal

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Intel grants Atom chip access to stealth startup RosaicLabs in rare IP deal. The startup, led by Amarjit Gill, has ties to Intel CEO Lip-Bu Tan. Rosaic may seek $10 million seed funding. Intel stock fell 5.12% to $81.88.

powered bylight_fuzz_icon
46940463

*this image is generated using AI for illustrative purposes only.

Intel Corp. (NASDAQ: INTC) has reportedly granted stealth semiconductor startup RosaicLabs Inc. access to parts of its Atom processor technology, marking a rare move involving intellectual property the company has historically kept under tight control. According to a Reuters report citing documents it reviewed, Intel plans to provide Rosaic with register-transfer level, or RTL, code for the Atom technology. This arrangement allows Rosaic to develop customized designs using Intel’s underlying x86 architecture, a significant departure from Intel’s past practice of not broadly licensing portions of its x86 architecture or providing widespread access to Atom technology.

Atom processors are designed to consume relatively low amounts of power and produce less heat, making them suitable for mobile and edge-computing applications. By sharing this foundational technology, Intel may be exploring new ways to commercialize its processor intellectual property as it seeks to strengthen its position in an increasingly competitive semiconductor market. Intel did not immediately respond to requests for comment regarding the specific terms of the agreement.

Leadership Ties to Intel CEO

RosaicLabs Inc., incorporated in Delaware in May, has maintained a low public profile with no website or LinkedIn page identified by the publication. Such secrecy is common among early-stage semiconductor startups working on proprietary chip designs. The startup is led by Amarjit Gill, a veteran chip-industry executive and venture investor who has worked closely with Intel CEO Lip-Bu Tan.

Gill helped Tan assemble the founding team at Rivos, a chip startup that Meta Platforms, Inc. (NASDAQ: META) acquired last year after reportedly outbidding Intel. Tan served as Rivos’ chairman at the time. Tan and Gill also made early-stage investments in Nuvia, a chip startup that Qualcomm Inc. (NASDAQ: QCOM) later acquired. Rosaic’s founding team includes several Rivos veterans; Amit Parikh, Rivos’ former finance chief, signed Rosaic’s incorporation documents.

Financial Structure and Market Reaction

An amended Delaware filing dated July 24 outlined Rosaic’s equity structure, including its preferred and common shares. Reuters’ analysis indicated that the startup could seek a seed funding round of about $10 million. The filing also allows company executives to make capital expenditures below $5 million without requiring approval from investors or the board.

In market trading, Intel closed Wednesday’s session at $81.88, down 5.12%, while the stock slipped another 0.86% to $81.18 in after-hours trading, according to Benzinga Pro. According to Benzinga Edge Rankings, Intel places in the 99th percentile for Momentum, signaling a strong long-term price trend even as the shares face short- and medium-term pressure.

Key Deal Details

Entity Detail
Startup Name RosaicLabs Inc.
Technology Access Atom Processor RTL Code
Key Executive Amarjit Gill
Potential Seed Round $10 million
Capex Limit $5 million

What the Numbers Show

The reported arrangement highlights a strategic pivot for Intel in how it leverages its legacy assets. While the stock experienced a 5.12% decline on Wednesday, closing at $81.88, the company maintains high momentum rankings. The decision to share Atom technology with a startup led by executives closely tied to CEO Lip-Bu Tan suggests an internal alignment on exploring new commercialization avenues for x86-based low-power processors, potentially diversifying revenue streams beyond traditional silicon sales.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might Intel's decision to license Atom RTL code signal a broader strategic shift toward an IP-licensing business model to offset declining silicon margins?

Given the close ties between RosaicLabs' leadership and Intel CEO Lip-Bu Tan, will this partnership face regulatory scrutiny regarding conflicts of interest or preferential treatment?

Could RosaicLabs' customized x86 designs for edge computing cannibalize Intel's own low-power processor sales, or are they targeting distinct market segments?

like17
dislike

Intel stock rises 1.3% in premarket as tech sector recovers

scanx
Reviewed by
ScanX News Team
Key Highlights

Intel Corp shares recovered 1.30% to $87.42 in premarket trading, driven by broader tech sector gains. While short-term technical indicators remain weak with the stock well below its 20- and 50-day moving averages, the long-term trend remains robust. Analysts maintain a Hold consensus with a $109.07 target, while Bank of America raised its target to $160.

powered bylight_fuzz_icon
46777900

*this image is generated using AI for illustrative purposes only.

Intel Corp shares gained 1.30% in Wednesday’s premarket session, trading at $87.42, reversing the nearly 4% decline seen in Tuesday’s trading. The rebound aligns with a broader risk-on sentiment across technology stocks, with Nasdaq futures rising 0.26% and S&P 500 futures up 0.23%. Investors appear to be positioning after Intel’s sharp pullback from its June highs, assessing whether the stock can stabilize near critical technical support levels despite ongoing near-term weakness.

The stock remains significantly below its short-term moving averages, trading 17.7% below its 20-day simple moving average (SMA) of $106.69 and 23% below its 50-day SMA of $114.10. This gap suggests that sellers continue to control the immediate trend. However, the long-term outlook remains intact, with shares sitting approximately 32.5% above the 200-day SMA of $66.28. The 100-day SMA at $91.17 has emerged as the next key resistance level; a break above this point could signal improved technical conditions and open the path toward testing higher moving averages.

Technical Levels and Momentum

Momentum indicators remain cautious, with the moving average convergence divergence (MACD) indicator staying below its signal line. This configuration indicates that bullish momentum has not yet returned, although the stock’s high Momentum score of 99.09 suggests it retains strength relative to the broader market. Traders are monitoring whether Intel can establish higher lows following its swing low in July, with support currently identified near $74.93, close to the 200-day exponential moving average.

Level Type Price Reference
Resistance $91.17 100-day SMA
Support $74.93 Near 200-day EMA

Analyst Outlook and ETF Exposure

Intel maintains a consensus Hold rating with an average analyst price forecast of $109.07. Recent analyst actions reflect mixed but cautiously optimistic views:

  • Bank of America Securities maintained a Buy rating and raised its price forecast to $160 on July 28.
  • Baird maintained a Neutral rating and raised its price forecast to $125 on July 27.
  • DA Davidson maintained a Neutral rating and raised its price forecast to $100 on July 24.

Intel is a significant holding in several semiconductor-focused exchange-traded funds, which can influence share demand through passive investment flows:

ETF Name Ticker Weighting
VanEck Semiconductor ETF SMH 7.36%
Invesco PHLX Semiconductor ETF SOXQ 6.64%
Invesco AI and Next Gen Software ETF IGPT 7.25%

What the Numbers Show

Despite the recent volatility, Intel’s position 32.5% above its 200-day SMA underscores the resilience of its long-term uptrend, which includes a 322.83% gain over the past 12 months. The current consolidation phase appears to be a healthy correction rather than a structural breakdown, provided the stock holds above the $74.93 support level. The divergence between the weak short-term momentum and strong long-term trend suggests that traders are waiting for confirmation of stabilization near the 100-day SMA before committing to new long positions.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific catalysts or earnings metrics are required for Intel to decisively break above the $91.17 resistance level and validate a trend reversal?

How might the recent price target increases by Bank of America and Baird influence institutional buying pressure if the stock stabilizes near the $74.93 support?

Could heavy passive inflows into semiconductor ETFs like SMH and SOXQ provide sufficient demand to offset the current seller dominance in the short term?

like19
dislike

More News on Intel